Difficulty: Medium
Average Score: 79%
Practice
Lovastatin (Mevacor) plus a bile-acid binding resin causes regression of coronary lesions in about one third of treated patients. This consideration is:
Correct answer
A
Rationale
The correct answer is A: TRUE. Lovastatin combined with a bile-acid binding resin has been shown to cause regression of coronary lesions in about one third of treated patients. This is supported by clinical studies and research, demonstrating the effectiveness of this combination therapy in improving coronary health. The other choices are incorrect because they do not accurately reflect the evidence and outcomes of this specific treatment approach. Choice B (FALSE) is incorrect because there is evidence to support the regression of coronary lesions with this treatment. Choice C (All) is incorrect because not all patients treated with this combination therapy experience regression of coronary lesions. Choice D (None) is incorrect as there is a significant proportion of patients who do benefit from this treatment in terms of lesion regression.